Immunophenotypical Changes in Chronic Lymphocytic Leukemia with Hepatitis Infections
Author Information
Author(s): Bumbea H, Vladareanu AM, Vintilescu A, Radesi S, Ciufu C, Onisai M, Baluta C, Begu M, Dobrea C, Arama V, Streinu–Cercel A, Arama S
Primary Institution: Hematology Department, Universitary Emergency Hospital, Bucharest, Romania
Hypothesis
The study aims to detect immunophenotype changes of malignant lymphocytes in chronic lymphoproliferative disorders, particularly chronic lymphocytic leukemia (CLL), associated with hepatitis viral infections.
Conclusion
The study suggests that hepatitis viral infections may lead to atypical immunophenotypical changes in CLL, indicating a more aggressive disease.
Supporting Evidence
- Patients with CLL and viral infections showed higher expression of B-cell markers like CD19 and CD20.
- Poor prognosis markers such as CD38 and Bcl2 were also found to be elevated in patients with viral infections.
- The study found a higher frequency of HCV infection in patients with chronic lymphoproliferative disorders.
Takeaway
This study looks at how certain viruses can change the way cancer cells in the blood look, which might make the cancer harder to treat.
Methodology
The study analyzed bone marrow aspirate and peripheral blood samples from 58 patients diagnosed with chronic lymphoproliferative disorders associated with hepatitis virus infections, focusing on immunophenotypical markers.
Limitations
The study is limited by its observational nature and the relatively small sample size.
Participant Demographics
The patient group comprised 58 patients with a male/female ratio of 1/2 and an average age of 64 years.
Statistical Information
P-Value
p=0.004
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website